Table 1.
All features | Non-normal features | ||||||||
---|---|---|---|---|---|---|---|---|---|
n | DE% | SDA | 2T | 2W | ELRT | SDA | 2T | 2W | ELRT |
50 | 5 | 0.89 | 0.88 | 0.88 | 0.78 | 0.93 | 0.88 | 0.90 | 0.75 |
10 | 0.89 | 0.88 | 0.88 | 0.78 | 0.94 | 0.88 | 0.91 | 0.77 | |
20 | 0.89 | 0.88 | 0.88 | 0.78 | 0.93 | 0.88 | 0.91 | 0.76 | |
100 | 5 | 0.97 | 0.95 | 0.95 | 0.89 | 0.98 | 0.95 | 0.97 | 0.88 |
10 | 0.97 | 0.95 | 0.95 | 0.88 | 0.98 | 0.95 | 0.97 | 0.87 | |
20 | 0.97 | 0.95 | 0.95 | 0.89 | 0.98 | 0.95 | 0.96 | 0.88 |
The AUCs based on all features and non-normal features (Shapiro-Wilk test p-value <0.01 for at least one of the two groups) were both reported. Results were based on an average over 100 replicates